$5.88
Price
$2.0B
Market Cap
—
P/E Ratio
10.7
Forward P/E
$-0.49
EPS (TTM)
—
Dividend Yield
$549M
Cash
$9M
Total Debt
342M
Shares Out
$1.54
$9.75
52-Week Range
Institutional Ownership of NUVATION BIO INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Abrams Capital Management|David Abrams
|
3.8M | $34M | $10.87 | -43.49% |
Trading Activity for NUVATION BIO INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2023-Q1 | |||||
| SELL | EXIT | — | — | $2.06 | |
| 2022-Q4 | |||||
| SELL | -53.9% | 4.8M | $9M | $1.99 | |
| 2022-Q2 | |||||
| SELL | -0.2% | 10.4M | $34M | $4.14 | |
| 2022-Q1 | |||||
| BUY | +21.1% | 10.4M | $55M | $5.40 | |
| 2021-Q1 | |||||
| BUY | NEW | 8.6M | $82M | $10.87 | |
| BUY | NEW | 3.8M | $34M | $10.87 | |
Insider Trading for NUVATION BIO INC
6 Months Insider Sentiment
Buy $0
Sell $6.2M
0
Buys
10
Sells
-6.2M
Net
0
Grants
Largest
$2.2M
Hattersley
$1.4M
Hanley
$1.2M
Liu
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 01, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | SELL | 150.0K | $7.82 | $1.2M |
| Dec 01, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | EXERCISE | 150.0K | $2.93 | $440K |
| Nov 26, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | SELL | 10.0K | $8.00 | $80K |
| Nov 26, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | EXERCISE | 10.0K | $3.61 | $36K |
| Nov 25, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | EXERCISE | 10.0K | $3.61 | $36K |
| Nov 25, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | SELL | 10.0K | $7.50 | $75K |
| Nov 20, 2025 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | SELL | 300.0K | $7.23 | $2.2M |
| Nov 20, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | EXERCISE | 20.0K | $1.87 | $37K |
| Nov 20, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | SELL | 20.0K | $7.00 | $140K |
| Nov 20, 2025 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | EXERCISE | 69.1K | $1.74 | $120K |
| Nov 20, 2025 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | EXERCISE | 300.0K | $1.94 | $582K |
| Nov 20, 2025 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | SELL | 69.1K | $7.23 | $499K |
| Nov 19, 2025 | David C. Hanley | CHIEF TECHNICAL OPERATIONS | EXERCISE | 200.0K | $1.87 | $374K |
| Nov 19, 2025 | David C. Hanley | CHIEF TECHNICAL OPERATIONS | SELL | 200.0K | $7.14 | $1.4M |
| Nov 19, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | EXERCISE | 15.0K | $1.87 | $28K |
| Nov 19, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | SELL | 15.0K | $5.10 | $77K |
| Nov 17, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | SELL | 15.0K | $4.76 | $71K |
| Nov 17, 2025 | Dongfang Liu | CHIEF MEDICAL OFFICER | EXERCISE | 15.0K | $1.87 | $28K |
| Oct 27, 2025 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | EXERCISE | 100.0K | $1.74 | $174K |
| Oct 27, 2025 | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | SELL | 100.0K | $5.02 | $502K |